Cancer cells frequently are homozygous for loss-offunction...

Cancer cells frequently are homozygous for loss-offunction mutations in the $T P 53$ gene, and many of these mutations map in the portion of $T P 53$ that encodes the DNA-binding domain of $p 53 .$ Explain how these mutations contribute to the cancerous phenotype of the cells.

Key Concepts

Tumor Suppressor Genes

Tumor suppressor genes are critical regulators of cell growth and division. They function to prevent uncontrolled cell proliferation by ensuring that cells only divide when appropriate, repairing DNA damage, or triggering apoptosis (programmed cell death) if the damage is irreparable. Loss-of-function mutations in these genes remove these protective mechanisms and can lead to tumorigenesis.

p53 Protein Function

The p53 protein, encoded by the TP53 gene, is one of the most prominent tumor suppressors in the human body. It acts as a transcription factor that regulates the expression of a variety of genes involved in cell cycle arrest, apoptosis, and DNA repair. By doing so, p53 serves as a guardian of the genome, maintaining genetic stability by preventing the propagation of cells that have incurred DNA damage.

DNA-Binding Domain

The DNA-binding domain of p53 is a key structural feature that allows the protein to attach to specific DNA sequences in the regulatory regions of its target genes. This binding is essential for the transcriptional activation of genes that control cell cycle progression and cell death. Mutations in this domain compromise p53’s ability to bind DNA, thereby disabling its regulatory functions.

Loss-of-Function Mutations

Loss-of-function mutations, particularly those affecting the DNA-binding domain of p53, result in an inactive protein that cannot control cell division or initiate apoptosis in response to DNA damage. When these mutations occur in both alleles (homozygous), the cell loses a critical checkpoint mechanism, leading to unchecked cell proliferation and an increased likelihood of accumulating additional genetic abnormalities that drive cancer development.

Transcript

Please give Ace some feedback